Urinary incontinence (women)
Current Care Summary |  Published: 2017-09-05  
Working group appointed by the Finnish Medical Society Duodecim and the Finnish Gynaecological Association
Print

Urinary incontinence (women)

Current Care Summary
5.9.2017
Working group appointed by the Finnish Medical Society Duodecim and the Finnish Gynaecological Association

Current Care Guideline «Virtsankarkailu (naiset)»1 and Summary «Virtsankarkailu (naiset)»2 in Finnish

Risk factors for urinary incontinence in women are overweight and obesity, pregnancy and child birth, smoking, diabetes, many neurological diseases and, especially among older people, certain medication. Pelvic muscle training reduces stress incontinence. For urge incontinence, anticholinergic drugs and mirabegron are equally effective, but have a different side-effect profile. For postmenopausal women, intravaginal estrogen treatment is recommended. For stress incontinence, retoropubic and trans-obturator operations are equally effective, and they have no absolute contraindications. Surgical treatment for stress incontinence and conservative treatment for urge incontinence may well be combined.

Tomi Mikkola (chair)

Seija Ala-Nissilä

Olavi Airaksinen

Pauliina Aukee

Maria Nuotio

Ilkka Perttilä

Kaisa Raatikainen

Juhani Ruutiainen

Eeva Sundström

Minna Törnävä

Piia Vuorela

Current Care Guidelines are independent, evidence-based clinical practice guidelines. These national guidelines cover important issues related to Finnish health, medical treatment as well as prevention of diseases. Learn more